HEADER HYDROLASE 21-DEC-04 1YBW TITLE PROTEASE DOMAIN OF HGFA WITH NO INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR ACTIVATOR PRECURSOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HGF ACTIVATOR, HGFA; COMPND 5 EC: 3.4.21.-; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HGFAC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PACGP67A KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.SHIA,J.STAMOS,D.KIRCHHOFER,B.FAN,J.WU,R.T.CORPUZ,L.SANTELL, AUTHOR 2 R.A.LAZARUS,C.EIGENBROT REVDAT 5 23-AUG-23 1YBW 1 REMARK HETSYN REVDAT 4 29-JUL-20 1YBW 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE REVDAT 3 13-JUL-11 1YBW 1 VERSN REVDAT 2 24-FEB-09 1YBW 1 VERSN REVDAT 1 15-FEB-05 1YBW 0 JRNL AUTH S.SHIA,J.STAMOS,D.KIRCHHOFER,B.FAN,J.WU,R.T.CORPUZ, JRNL AUTH 2 L.SANTELL,R.A.LAZARUS,C.EIGENBROT JRNL TITL CONFORMATIONAL LABILITY IN SERINE PROTEASE ACTIVE SITES: JRNL TITL 2 STRUCTURES OF HEPATOCYTE GROWTH FACTOR ACTIVATOR (HGFA) JRNL TITL 3 ALONE AND WITH THE INHIBITORY DOMAIN FROM HGFA INHIBITOR-1B. JRNL REF J.MOL.BIOL. V. 346 1335 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 15713485 JRNL DOI 10.1016/J.JMB.2004.12.048 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2000.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,MOLECULAR REMARK 3 : SIMULATIONS (BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1036637.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 14974 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.218 REMARK 3 R VALUE (WORKING SET) : 0.213 REMARK 3 FREE R VALUE : 0.256 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.900 REMARK 3 FREE R VALUE TEST SET COUNT : 436 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.012 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 14974 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1429 REMARK 3 BIN R VALUE (WORKING SET) : 0.3070 REMARK 3 BIN FREE R VALUE : 0.3040 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 41 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.048 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3756 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 110 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.11000 REMARK 3 B22 (A**2) : -9.70000 REMARK 3 B33 (A**2) : -4.41000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 9.71000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.38 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.45 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.900 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.630 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.750 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.640 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.420 ; 2.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 28.67 REMARK 3 REMARK 3 NCS MODEL : CONSTR REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : 0.03 ; 1000 REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 GROUP 2 POSITIONAL (A) : 0.03 ; 500 REMARK 3 GROUP 2 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : CARBOHYDRATE.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1YBW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JAN-05. REMARK 100 THE DEPOSITION ID IS D_1000031357. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-DEC-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.917 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14974 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.12700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1DAN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.23 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 10K, PH 7.2, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 38.21500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 373 REMARK 465 GLN A 374 REMARK 465 LEU A 375 REMARK 465 SER A 376 REMARK 465 PRO A 377 REMARK 465 ASP A 378 REMARK 465 LEU A 379 REMARK 465 LEU A 380 REMARK 465 ALA A 381 REMARK 465 THR A 382 REMARK 465 LEU A 383 REMARK 465 PRO A 384 REMARK 465 GLU A 385 REMARK 465 PRO A 386 REMARK 465 ALA A 387 REMARK 465 SER A 388 REMARK 465 PRO A 389 REMARK 465 GLY A 390 REMARK 465 ARG A 391 REMARK 465 GLN A 392 REMARK 465 ARG A 401 REMARK 465 THR A 402 REMARK 465 PHE A 403 REMARK 465 LEU A 404 REMARK 465 ARG A 405 REMARK 465 PRO A 406 REMARK 465 ARG A 407 REMARK 465 ARG A 646 REMARK 465 PRO A 647 REMARK 465 PRO A 648 REMARK 465 ARG A 649 REMARK 465 ARG A 650 REMARK 465 LEU A 651 REMARK 465 VAL A 652 REMARK 465 ALA A 653 REMARK 465 PRO A 654 REMARK 465 SER A 655 REMARK 465 VAL B 373 REMARK 465 GLN B 374 REMARK 465 LEU B 375 REMARK 465 SER B 376 REMARK 465 PRO B 377 REMARK 465 ASP B 378 REMARK 465 LEU B 379 REMARK 465 LEU B 380 REMARK 465 ALA B 381 REMARK 465 THR B 382 REMARK 465 LEU B 383 REMARK 465 PRO B 384 REMARK 465 GLU B 385 REMARK 465 PRO B 386 REMARK 465 ALA B 387 REMARK 465 SER B 388 REMARK 465 PRO B 389 REMARK 465 GLY B 390 REMARK 465 ARG B 391 REMARK 465 GLN B 392 REMARK 465 ARG B 401 REMARK 465 THR B 402 REMARK 465 PHE B 403 REMARK 465 LEU B 404 REMARK 465 ARG B 405 REMARK 465 PRO B 406 REMARK 465 ARG B 407 REMARK 465 ARG B 646 REMARK 465 PRO B 647 REMARK 465 PRO B 648 REMARK 465 ARG B 649 REMARK 465 ARG B 650 REMARK 465 LEU B 651 REMARK 465 VAL B 652 REMARK 465 ALA B 653 REMARK 465 PRO B 654 REMARK 465 SER B 655 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 LYS A 481 CE NZ REMARK 480 GLU A 545 CG CD OE1 OE2 REMARK 480 ASN A 546 CG OD1 ND2 REMARK 480 VAL A 547 CG1 CG2 REMARK 480 LEU A 625 CG CD1 CD2 REMARK 480 LYS B 481 CE NZ REMARK 480 ASP B 508 CG OD1 OD2 REMARK 480 GLU B 545 CG CD OE1 OE2 REMARK 480 ASN B 546 CG OD1 ND2 REMARK 480 VAL B 547 CG1 CG2 REMARK 480 LEU B 625 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 602 N - CA - C ANGL. DEV. = -17.4 DEGREES REMARK 500 LEU B 602 N - CA - C ANGL. DEV. = -17.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 398 -4.88 86.54 REMARK 500 HIS A 451 14.23 -69.56 REMARK 500 SER A 452 78.13 33.64 REMARK 500 ASP A 456 0.86 -59.50 REMARK 500 PHE A 467 -75.71 -28.12 REMARK 500 THR A 471 -155.15 -129.34 REMARK 500 ASN A 492 74.09 -161.13 REMARK 500 ARG A 509 -71.64 -120.48 REMARK 500 CYS A 510 -156.35 94.76 REMARK 500 SER A 514 -177.31 -177.23 REMARK 500 VAL A 572 -82.79 -124.48 REMARK 500 CYS A 589 -105.68 45.61 REMARK 500 LYS A 590 -111.48 54.60 REMARK 500 SER A 617 -111.25 -89.17 REMARK 500 LEU A 625 97.10 -58.89 REMARK 500 HIS A 626 -30.13 -38.40 REMARK 500 PRO A 628 -178.74 -66.52 REMARK 500 HIS B 398 -4.99 86.40 REMARK 500 HIS B 451 14.19 -69.69 REMARK 500 SER B 452 77.79 33.82 REMARK 500 ASP B 456 0.79 -59.70 REMARK 500 PHE B 467 -76.11 -28.15 REMARK 500 THR B 471 -155.06 -129.15 REMARK 500 ASN B 492 74.03 -161.43 REMARK 500 ARG B 509 -71.92 -120.29 REMARK 500 CYS B 510 -156.00 95.17 REMARK 500 SER B 514 -177.77 -176.83 REMARK 500 VAL B 572 -82.75 -124.39 REMARK 500 CYS B 589 -105.76 45.54 REMARK 500 LYS B 590 -111.45 54.64 REMARK 500 SER B 617 -111.75 -90.02 REMARK 500 LEU B 625 96.82 -58.94 REMARK 500 HIS B 626 -30.33 -37.86 REMARK 500 PRO B 628 -178.52 -66.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 4 REMARK 615 HOH B 104 DBREF 1YBW A 373 655 UNP Q04756 HGFA_HUMAN 373 655 DBREF 1YBW B 373 655 UNP Q04756 HGFA_HUMAN 373 655 SEQRES 1 A 283 VAL GLN LEU SER PRO ASP LEU LEU ALA THR LEU PRO GLU SEQRES 2 A 283 PRO ALA SER PRO GLY ARG GLN ALA CYS GLY ARG ARG HIS SEQRES 3 A 283 LYS LYS ARG THR PHE LEU ARG PRO ARG ILE ILE GLY GLY SEQRES 4 A 283 SER SER SER LEU PRO GLY SER HIS PRO TRP LEU ALA ALA SEQRES 5 A 283 ILE TYR ILE GLY ASP SER PHE CYS ALA GLY SER LEU VAL SEQRES 6 A 283 HIS THR CYS TRP VAL VAL SER ALA ALA HIS CYS PHE SER SEQRES 7 A 283 HIS SER PRO PRO ARG ASP SER VAL SER VAL VAL LEU GLY SEQRES 8 A 283 GLN HIS PHE PHE ASN ARG THR THR ASP VAL THR GLN THR SEQRES 9 A 283 PHE GLY ILE GLU LYS TYR ILE PRO TYR THR LEU TYR SER SEQRES 10 A 283 VAL PHE ASN PRO SER ASP HIS ASP LEU VAL LEU ILE ARG SEQRES 11 A 283 LEU LYS LYS LYS GLY ASP ARG CYS ALA THR ARG SER GLN SEQRES 12 A 283 PHE VAL GLN PRO ILE CYS LEU PRO GLU PRO GLY SER THR SEQRES 13 A 283 PHE PRO ALA GLY HIS LYS CYS GLN ILE ALA GLY TRP GLY SEQRES 14 A 283 HIS LEU ASP GLU ASN VAL SER GLY TYR SER SER SER LEU SEQRES 15 A 283 ARG GLU ALA LEU VAL PRO LEU VAL ALA ASP HIS LYS CYS SEQRES 16 A 283 SER SER PRO GLU VAL TYR GLY ALA ASP ILE SER PRO ASN SEQRES 17 A 283 MET LEU CYS ALA GLY TYR PHE ASP CYS LYS SER ASP ALA SEQRES 18 A 283 CYS GLN GLY ASP SER GLY GLY PRO LEU ALA CYS GLU LYS SEQRES 19 A 283 ASN GLY VAL ALA TYR LEU TYR GLY ILE ILE SER TRP GLY SEQRES 20 A 283 ASP GLY CYS GLY ARG LEU HIS LYS PRO GLY VAL TYR THR SEQRES 21 A 283 ARG VAL ALA ASN TYR VAL ASP TRP ILE ASN ASP ARG ILE SEQRES 22 A 283 ARG PRO PRO ARG ARG LEU VAL ALA PRO SER SEQRES 1 B 283 VAL GLN LEU SER PRO ASP LEU LEU ALA THR LEU PRO GLU SEQRES 2 B 283 PRO ALA SER PRO GLY ARG GLN ALA CYS GLY ARG ARG HIS SEQRES 3 B 283 LYS LYS ARG THR PHE LEU ARG PRO ARG ILE ILE GLY GLY SEQRES 4 B 283 SER SER SER LEU PRO GLY SER HIS PRO TRP LEU ALA ALA SEQRES 5 B 283 ILE TYR ILE GLY ASP SER PHE CYS ALA GLY SER LEU VAL SEQRES 6 B 283 HIS THR CYS TRP VAL VAL SER ALA ALA HIS CYS PHE SER SEQRES 7 B 283 HIS SER PRO PRO ARG ASP SER VAL SER VAL VAL LEU GLY SEQRES 8 B 283 GLN HIS PHE PHE ASN ARG THR THR ASP VAL THR GLN THR SEQRES 9 B 283 PHE GLY ILE GLU LYS TYR ILE PRO TYR THR LEU TYR SER SEQRES 10 B 283 VAL PHE ASN PRO SER ASP HIS ASP LEU VAL LEU ILE ARG SEQRES 11 B 283 LEU LYS LYS LYS GLY ASP ARG CYS ALA THR ARG SER GLN SEQRES 12 B 283 PHE VAL GLN PRO ILE CYS LEU PRO GLU PRO GLY SER THR SEQRES 13 B 283 PHE PRO ALA GLY HIS LYS CYS GLN ILE ALA GLY TRP GLY SEQRES 14 B 283 HIS LEU ASP GLU ASN VAL SER GLY TYR SER SER SER LEU SEQRES 15 B 283 ARG GLU ALA LEU VAL PRO LEU VAL ALA ASP HIS LYS CYS SEQRES 16 B 283 SER SER PRO GLU VAL TYR GLY ALA ASP ILE SER PRO ASN SEQRES 17 B 283 MET LEU CYS ALA GLY TYR PHE ASP CYS LYS SER ASP ALA SEQRES 18 B 283 CYS GLN GLY ASP SER GLY GLY PRO LEU ALA CYS GLU LYS SEQRES 19 B 283 ASN GLY VAL ALA TYR LEU TYR GLY ILE ILE SER TRP GLY SEQRES 20 B 283 ASP GLY CYS GLY ARG LEU HIS LYS PRO GLY VAL TYR THR SEQRES 21 B 283 ARG VAL ALA ASN TYR VAL ASP TRP ILE ASN ASP ARG ILE SEQRES 22 B 283 ARG PRO PRO ARG ARG LEU VAL ALA PRO SER MODRES 1YBW ASN A 468 ASN GLYCOSYLATION SITE MODRES 1YBW ASN B 468 ASN GLYCOSYLATION SITE HET NAG A 741 14 HET NAG B 742 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 2(C8 H15 N O6) FORMUL 5 HOH *110(H2 O) HELIX 1 1 ALA A 445 PHE A 449 5 5 HELIX 2 2 PRO A 454 ASP A 456 5 3 HELIX 3 3 ALA A 563 SER A 569 1 7 HELIX 4 4 TYR A 637 ASP A 643 1 7 HELIX 5 5 ALA B 445 PHE B 449 5 5 HELIX 6 6 PRO B 454 ASP B 456 5 3 HELIX 7 7 ALA B 563 SER B 569 1 7 HELIX 8 8 TYR B 637 ASP B 643 1 7 SHEET 1 A 7 SER A 412 SER A 413 0 SHEET 2 A 7 ARG A 555 PRO A 560 -1 O GLU A 556 N SER A 412 SHEET 3 A 7 LYS A 534 GLY A 539 -1 N CYS A 535 O VAL A 559 SHEET 4 A 7 PRO A 601 LYS A 606 -1 O ALA A 603 N GLN A 536 SHEET 5 A 7 VAL A 609 ILE A 616 -1 O TYR A 611 N CYS A 604 SHEET 6 A 7 GLY A 629 ARG A 633 -1 O THR A 632 N ILE A 615 SHEET 7 A 7 MET A 581 ALA A 584 -1 N LEU A 582 O TYR A 631 SHEET 1 B 7 GLN A 475 PHE A 477 0 SHEET 2 B 7 VAL A 458 LEU A 462 -1 N LEU A 462 O GLN A 475 SHEET 3 B 7 LEU A 422 ILE A 427 -1 N TYR A 426 O SER A 459 SHEET 4 B 7 SER A 430 HIS A 438 -1 O GLY A 434 N ALA A 423 SHEET 5 B 7 TRP A 441 SER A 444 -1 O VAL A 443 N SER A 435 SHEET 6 B 7 VAL A 499 LEU A 503 -1 O ILE A 501 N VAL A 442 SHEET 7 B 7 ILE A 479 PRO A 484 -1 N ILE A 483 O LEU A 500 SHEET 1 C 7 SER B 412 SER B 413 0 SHEET 2 C 7 ARG B 555 PRO B 560 -1 O GLU B 556 N SER B 412 SHEET 3 C 7 LYS B 534 GLY B 539 -1 N CYS B 535 O VAL B 559 SHEET 4 C 7 PRO B 601 LYS B 606 -1 O ALA B 603 N GLN B 536 SHEET 5 C 7 VAL B 609 ILE B 616 -1 O TYR B 611 N CYS B 604 SHEET 6 C 7 GLY B 629 ARG B 633 -1 O THR B 632 N ILE B 615 SHEET 7 C 7 MET B 581 ALA B 584 -1 N LEU B 582 O TYR B 631 SHEET 1 D 7 GLN B 475 PHE B 477 0 SHEET 2 D 7 VAL B 458 LEU B 462 -1 N LEU B 462 O GLN B 475 SHEET 3 D 7 LEU B 422 ILE B 427 -1 N TYR B 426 O SER B 459 SHEET 4 D 7 SER B 430 HIS B 438 -1 O GLY B 434 N ALA B 423 SHEET 5 D 7 TRP B 441 SER B 444 -1 O VAL B 443 N SER B 435 SHEET 6 D 7 VAL B 499 LEU B 503 -1 O VAL B 499 N SER B 444 SHEET 7 D 7 ILE B 479 PRO B 484 -1 N ILE B 483 O LEU B 500 SSBOND 1 CYS A 394 CYS A 521 1555 1555 2.44 SSBOND 2 CYS A 432 CYS A 448 1555 1555 2.52 SSBOND 3 CYS A 440 CYS A 510 1555 1555 2.72 SSBOND 4 CYS A 535 CYS A 604 1555 1555 2.71 SSBOND 5 CYS A 567 CYS A 583 1555 1555 2.05 SSBOND 6 CYS B 394 CYS B 521 1555 1555 2.43 SSBOND 7 CYS B 432 CYS B 448 1555 1555 2.54 SSBOND 8 CYS B 440 CYS B 510 1555 1555 2.74 SSBOND 9 CYS B 535 CYS B 604 1555 1555 2.68 SSBOND 10 CYS B 567 CYS B 583 1555 1555 2.05 LINK ND2 ASN A 468 C1 NAG A 741 1555 1555 1.45 LINK ND2 ASN B 468 C1 NAG B 742 1555 1555 1.45 CRYST1 52.430 76.430 72.150 90.00 107.77 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019073 0.000000 0.006113 0.00000 SCALE2 0.000000 0.013084 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014554 0.00000